EUCTR2017-005074-19-BE进行中(未招募)1 期
Minimal optimal dose of Sugammadex during ambulatory surgery in dentistry - SDDS
Erasme Hospital0 个研究点目标入组 40 人开始时间: 2019年3月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- minor patients;
- •- patients refusing to sign consent;
- •- patients included in another protocol within 3 months;
- •- pregnant or nursing patients;
- •- patients with a history of allergy to Sugammadex;
- •- patients with known neuromuscular disease
- •- patients with renal or hepatic impairment.
研究者
相似试验
已完成
不适用
Optimal reversal dose of Sugammadex in a short post-operative period in adult patientsthe patients scheduled for elective surgery requiring general anesthesiaJPRN-UMIN000007245Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University40
已完成
不适用
Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.Patients scheduled for elective surgery requiring general anesthesiaJPRN-UMIN000025218Department of Anesthesiology Nihon University School of Medicine40
尚未招募
4 期
se of sugammadex to reverse moderate to deep neuromuscular blockade.CTRI/2024/07/069838Dr D Jayshree
进行中(未招募)
1 期
Sugammadex dose-finding study for reversal of deep rocuronium-induced neuromuscular blockEUCTR2019-000709-55-BEniversitair Ziekenhuis Brussel60
进行中(未招募)
1 期
Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade at a train of four ratio of 0.2] - SUNDRO20EUCTR2009-013499-29-DETechnische Universität München
